Ticker >

Novartis share price

Novartis India Ltd.

NSE: NOVARTIND BSE: 500672 SECTOR: Trading  26k   39   4

1118.00
0 0
BSE: 30 Aug 04:01 PM

Price Summary

Today's High

₹ 1125.05

Today's Low

₹ 1114

52 Week High

₹ 1240

52 Week Low

₹ 599.95

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

2760.43 Cr.

Enterprise Value

2164.37 Cr.

No. of Shares

2.47 Cr.

P/E

30.44

P/B

3.58

Face Value

₹ 5

Div. Yield

2.24 %

Book Value (TTM)

₹  312.09

CASH

596.08 Cr.

DEBT

0.02 Cr.

Promoter Holding

70.68 %

EPS (TTM)

₹  36.72

Sales Growth

-11.53%

ROE

11.21 %

ROCE

16.35%

Profit Growth

-17.58 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-11.53%
3 Year-4.22%
5 Year-7.35%

Profit Growth

1 Year-17.58%
3 Year59.74%
5 Year10.47%

ROE%

1 Year11.21%
3 Year8.25%
5 Year5.8%

ROCE %

1 Year16.35%
3 Year10.82%
5 Year8.77%

Debt/Equity

0

Price to Cash Flow

24.34

Interest Cover Ratio

83.443

CFO/PAT (5 Yr. Avg.)

0.484314906630833

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2024 70.68 0
Mar 2024 70.68 0
Dec 2023 70.68 0
Sep 2023 70.68 0
Jun 2023 70.68 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 59.7401583865764% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 83.443.
  • The company has an efficient Cash Conversion Cycle of -22.5777 days.
  • Company has a healthy liquidity position with current ratio of 2.3557.
  • The company has a high promoter holding of 70.68%.

 Limitations

  • The company has shown a poor revenue growth of -4.22089255009929% for the Past 3 years.
  • Company has contingent liabilities of 398.38 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 90.6 78.76 84.54 81.17 92.29
Total Expenditure 73.28 61.85 64.77 69.96 68.32
Operating Profit 17.32 16.91 19.77 11.21 23.97
Other Income 12.47 16.88 21.96 10.42 10.41
Interest 0.46 0.71 0.16 0.16 0.15
Depreciation 1.56 0.65 0.26 0.14 0.55
Exceptional Items 0 0 0 0 0
Profit Before Tax 27.77 32.43 41.31 21.33 33.68
Tax 7.51 8.75 14.74 6.65 7.94
Profit After Tax 20.26 23.68 26.57 14.68 25.74
Adjusted EPS (Rs) 8.21 9.59 10.77 5.95 10.43

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 438.25 381.35 399.87 378.74 335.07
Total Expenditure 426.51 355.66 373.12 313.66 269.81
Operating Profit 11.74 25.69 26.75 65.08 65.26
Other Income 36.43 34.19 33.55 58.11 61.68
Interest 6.39 7.68 4.83 1.75 1.49
Depreciation 13.14 12.16 9.65 6.06 2.61
Exceptional Items 0 0 -49.64 0 0
Profit Before Tax 28.64 40.04 -3.82 115.38 122.84
Tax 18.56 19.14 -0.1 12.02 37.65
Net Profit 10.08 20.9 -3.72 103.36 85.19
Adjusted EPS (Rs.) 4.08 8.47 -1.51 41.88 34.52

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 12.34 12.34 12.34 12.34 12.34
Total Reserves 708.39 698.85 679.36 763.32 732.48
Borrowings 0 0 0 0 0
Other N/C liabilities 99.38 1130.65 984 1007.77 716.25
Current liabilities 416.93 357.26 334.47 268.26 399.83
Total Liabilities 1237.04 2199.1 2010.17 2051.69 1860.9
Assets
Net Block 76.28 63.91 23.65 19.25 6.94
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 137.84 1186.01 1148.65 1240.75 903.63
Other N/C Assets 25.65 26.83 12 5.63 8.44
Current Assets 997.27 922.35 825.87 786.06 941.89
Total Assets 1237.04 2199.1 2010.17 2051.69 1860.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 28.64 40.04 -3.82 115.38 122.84
Adjustment -11.8 -4.98 -5.64 -48.92 -56.75
Changes in Assets & Liabilities -1.85 -69.08 66.72 -24 9.04
Tax Paid -38.13 -35.19 -18.59 2.34 38.27
Operating Cash Flow -23.14 -69.21 38.67 44.8 113.4
Investing Cash Flow 55.91 95.16 87.04 -153.25 33.13
Financing Cash Flow -41.41 -36.8 -35.63 -30.48 -120.99
Net Cash Flow -8.64 -10.85 90.08 -138.93 25.54

Corporate Actions

Investors Details

PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
promoters 70.68 70.68 70.68 70.68 70.68
novartis ag 70.68 70.68 70.68 70.68 70.68
PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
investors 29.32 29.32 29.32 29.32 29.32
atul limited 1.52 1.52 1.52 1.52 1.52
investor education and pr... 0.58 0.64 0.64 0.63 0.63
llp 0.34 0.35 0.35 0.37 0.30

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Novartis - Quaterly Results29 Jul 2024, 1:30PM Novartis - Quaterly Results29 Jul 2024, 1:30PM Novartis - Quaterly Results29 Jul 2024, 1:30PM Novartis India informs about loss of share certificate4 Jul 2024, 5:29PM Novartis India informs about loss of share certificate 15 May 2024, 5:06PM Novartis India informs about board meeting outcome 10 May 2024, 5:09PM Novartis - Quaterly Results10 May 2024, 4:09PM Novartis - Quaterly Results10 May 2024, 4:09PM Novartis - Quaterly Results10 May 2024, 4:09PM Novartis India informs about change in management8 May 2024, 5:23PM Novartis India informs about details of loss of certificate 19 Mar 2024, 2:50PM Novartis India informs about loss of share certificate28 Feb 2024, 2:55PM Novartis India informs about loss of share certificate27 Feb 2024, 11:40AM Novartis India informs about loss of share certificate 17 Feb 2024, 12:35PM Novartis India informs about outcome of board meeting 17 Feb 2024, 11:05AM Novartis India informs about details of loss of certificate 9 Feb 2024, 5:04PM Novartis India informs about newspaper publication27 Jan 2024, 9:44AM Novartis - Quaterly Results25 Jan 2024, 2:55PM Novartis - Quaterly Results25 Jan 2024, 2:55PM Novartis - Quaterly Results25 Jan 2024, 2:55PM Novartis India informs about details of loss of certificate6 Jan 2024, 3:33PM Novartis India informs about loss of share certificate2 Jan 2024, 2:20PM Novartis India informs about issuance of duplicate share certificate21 Dec 2023, 4:52PM Novartis India informs about details of loss of certificate 13 Dec 2023, 12:53PM Novartis India informs about details of loss of certificate12 Dec 2023, 4:58PM Novartis India informs about details of loss of certificate25 Nov 2023, 3:21PM Novartis India informs about details of loss of certificate22 Nov 2023, 4:11PM Novartis - Quaterly Results27 Oct 2023, 3:12PM Novartis - Quaterly Results27 Oct 2023, 3:12PM Novartis - Quaterly Results27 Oct 2023, 3:12PM Novartis India informs about closure of trading window30 Sep 2023, 4:23PM Novartis India submits board meeting intimation 30 Sep 2023, 3:47PM Novartis India informs about loss of share certificate 20 Sep 2023, 2:28PM Novartis India informs about loss of share certificate 12 Sep 2023, 10:28AM Novartis India informs about loss of share certificate28 Aug 2023, 4:14PM Novartis India informs about loss of share certificate25 Aug 2023, 12:11PM Novartis India informs about loss of share certificates14 Aug 2023, 2:41PM Novartis India informs about details of loss of certificate11 Aug 2023, 1:50PM Novartis India informs about details of loss of certificate9 Aug 2023, 1:03PM Novartis - Quaterly Results26 Jul 2023, 2:52PM Novartis - Quaterly Results26 Jul 2023, 2:52PM Novartis - Quaterly Results26 Jul 2023, 2:52PM Novartis India informs about compliances-certificate 5 Jul 2023, 4:31PM Novartis India informs about loss of share certificate3 Jul 2023, 2:24PM Novartis India informs about loss of share certificates24 Jun 2023, 12:56PM Novartis India informs about newspaper publication 11 May 2023, 2:06PM Novartis - Quaterly Results10 May 2023, 5:42PM Novartis - Quaterly Results10 May 2023, 5:42PM Novartis India informs about loss of share certificate25 Apr 2023, 2:41PM Novartis India informs about loss of share certificate15 Mar 2023, 5:08PM

Novartis Stock Price Analysis and Quick Research Report. Is Novartis an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Novartis stock price today is Rs 672.25. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Novartis . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Novartis has a PE ratio of 18.3063650870591 which is high and comparatively overvalued .

  • Share Price: - The current share price of Novartis is Rs 672.25. One can use valuation calculators of ticker to know if Novartis share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Novartis has ROA of 4.3547 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Novartis has a Current ratio of 2.3557 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Novartis has a ROE of 11.2054 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Novartis has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Novartis has reported revenue growth of -11.5303 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Novartis for the current financial year is 19.4765272928045 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Novartis is Rs 25 and the yield is 2.2474 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Novartis is Rs 36.7222 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Novartis in Ticker for free. Also, one can get the intrinsic value of Novartis by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Novartis
X